These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 881342)

  • 1. Cumulative dose calculations for clinical and diagnostic radionuclides.
    Singh DR
    Health Phys; 1977 May; 32(5):443-5. PubMed ID: 881342
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation exposure to nursing personnel from patients receiving diagnostic radionuclides.
    Burks J; Griffith P; McCormick K; Miller R
    Heart Lung; 1982; 11(3):217-20. PubMed ID: 6918386
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of zinc radionuclides.
    Berkley LW; Logan KW; Siegel E
    Health Phys; 1977 Apr; 32(4):303-5. PubMed ID: 881320
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of patient-specific radiation dose calculations for the administration of radionuclides in therapy.
    Siegel JA; Stabin MG; Brill AB
    Cell Mol Biol (Noisy-le-grand); 2002 Jul; 48(5):451-9. PubMed ID: 12146697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safe tracer dose in medical investigation.
    Saenger EL; Kereiakes JG
    Prog At Med; 1971; 3():139-65. PubMed ID: 4946936
    [No Abstract]   [Full Text] [Related]  

  • 7. A model of the peritoneal cavity for use in internal dosimetry.
    Watson EE; Stabin MG; Davis JL; Eckerman KF
    J Nucl Med; 1989 Dec; 30(12):2002-11. PubMed ID: 2585102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural background radiation: problem of radionuclide migration and biological effects].
    Aleksakhin RM; Knizhnikov VA; Taskaev AI
    Radiobiologiia; 1986; 26(3):292-301. PubMed ID: 3526391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occupational exposure to x-irradiation in Poland. Probability of exceeding the vital dosage].
    Jankowski J; Liniecki J; Krych B
    Pol Przegl Radiol Med Nukl; 1975; 39(3):387-94. PubMed ID: 1161561
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding radiotherapy.
    Lewis F; Levita M
    Cancer Nurs; 1988 Jun; 11(3):174-85. PubMed ID: 3401853
    [No Abstract]   [Full Text] [Related]  

  • 11. [System of radiation safety for medical personnel and patients in the USSR].
    Golikov VIa
    Med Radiol (Mosk); 1977 Nov; 22(11):50-3. PubMed ID: 927053
    [No Abstract]   [Full Text] [Related]  

  • 12. Time dependence of dose delivered to organs following the inhalation of radionuclides.
    Feather JI; de Beer GP
    Health Phys; 1981 Aug; 41(2):385-7. PubMed ID: 7275624
    [No Abstract]   [Full Text] [Related]  

  • 13. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic principles and standards for the radiation protection of patients during the diagnostic use of radioactively labeled substances].
    Agranat VZ; Guskova AK; Kniznikov VA; Lichtaev IA; Ljass FM
    Radiobiol Radiother (Berl); 1972; 13(6):625-32. PubMed ID: 4656723
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of technical and methodical progress on the patient dose in nuclear medicine].
    Pabst HW; Kretschko J
    Radiologe; 1970 Sep; 10(9):372-6. PubMed ID: 5479599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Computation of the maximum volumes of 11-C, 13-N, 15-O, and 18-F used daily applying the average figures of usage].
    Kakihara K; Kasida Y; Ido T
    Radioisotopes; 1982 Jul; 31(7):357-9. PubMed ID: 7178543
    [No Abstract]   [Full Text] [Related]  

  • 17. [First attempt at evaluating the overall risk induced in the diagnostic use of radionuclides (author's transl)].
    Mombelli L; Conte L
    Radiol Med; 1976 Dec; 62(12):991-1001. PubMed ID: 1027052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the genetically significant dose from diagnostic nuclear medicine examinations in the United States: 1980.
    Mettler FA; Williams AG; Spar JA; Kelsey CA
    Health Phys; 1986 Sep; 51(3):377-9. PubMed ID: 3744840
    [No Abstract]   [Full Text] [Related]  

  • 19. Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
    Rao DV; Howell RW
    J Nucl Med; 1993 Oct; 34(10):1801-10. PubMed ID: 8410301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of the maximum permissible levels of iodine radioisotopes].
    Zvonova IA; Likhtarev IA
    Gig Sanit; 1986 Jan; (1):50-3. PubMed ID: 3949212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.